Share this with
your friends

Thank You!


The SEE CLEAR I and SEE CLEAR II studies were phase 3, randomized, multicenter, assessor-blinded, active-control, non-inferiority studies in adult patients preparing for colonoscopy. The primary endpoints were overall colon cleansing with PREPOPIK vs a comparator (2L PEG+E plus 2x 5 mg bisacodyl tablets) using a modified version of the Aronchick scale. The secondary endpoints were the quality of cleansing of the ascending, mid (transverse and descending), and rectosigmoid segments of the colon using the Ottawa scale. Patients were also required to complete a questionnaire about orange-flavored PREPOPIK, which included the questions: "How easy or difficult was it to consume the study drug?" and "Would you ask your doctor for this preparation again if you needed another colonoscopy in the future?"1,2

PREPOPIK® IS A REGISTERED TRADEMARK OF FERRING B.V.
© 2015 FERRING B.V. ALL RIGHTS RESERVED.
PK/1190/2013/US(4)